GoodRx Holdings (GDRX) Treasury Shares (2020 - 2025)

GoodRx Holdings has disclosed Treasury Shares across 6 years of filings, most recently posting $20.0 million for Q4 2025.

• Treasury Shares for Q4 2025 came in at $20.0 million, down 10.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.0 million (down 10.59% YoY), and the FY2025 annual result was $20.0 million, down 10.59% from the prior year.
• Treasury Shares came in at $20.0 million for Q4 2025 at GoodRx Holdings, roughly flat from $20.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $22.4 million in Q4 2024 to a low of $469000.0 in Q3 2022.
• The 5-year median for Treasury Shares is $6.9 million (2021), against an average of $10.2 million.
• Across the five-year window, Treasury Shares sank 92.39% in 2022 and surged 1736.56% in 2024, its largest moves.
• GoodRx Holdings' Treasury Shares stood at $5.6 million in 2021, then surged by 49.8% to $8.5 million in 2022, then soared by 41.91% to $12.0 million in 2023, then soared by 86.41% to $22.4 million in 2024, then fell by 10.59% to $20.0 million in 2025.
• The last three Treasury Shares figures came in at $20.0 million (Q4 2025), $20.0 million (Q3 2025), and $20.0 million (Q2 2025), per Business Quant data.